Apoprotein E methylation is correlated with immune microenvironment in hepatocellular carcinoma

References

• Scheiner B, Pomej K, Kirstein MM, et al. Prognosis of patients with hepatocellular carcinoma treated with immunotherapy–development and validation of the CRAFITY score. J Hepatol. 2022;76(2):353–363. doi: 10.1016/j.jhep.2021.09.035.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi: 10.1016/S0140-6736(18)30010-2.
   PubMed Web of Science ®Google Scholar
• Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894–1905. doi: 10.1056/NEJMoa1915745.
   PubMed Web of Science ®Google Scholar
• Getz GS, Reardon CA. Apoprotein e and reverse cholesterol transport. Int J Mol Sci. 2018;19(11):3479.
   Web of Science ®Google Scholar
• Kulminski AM, Culminskaya I, Arbeev KG, et al. Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res. 2013;16(1):28–34. doi: 10.1089/rej.2012.1362.
   PubMed Web of Science ®Google Scholar
• Zhao N, Ren Y, Yamazaki Y, et al. Alzheimer’s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron. 2020;106(5):727–742.e6. doi: 10.1016/j.neuron.2020.02.034.
   PubMed Web of Science ®Google Scholar
• Butterbrod E, Sitskoorn M, Bakker M, et al. The APOE epsilon4 allele in relation to pre- and postsurgical cognitive functioning of patients with primary brain tumors. Eur J Neurol. 2021;28(5):1665–1676. doi: 10.1111/ene.14693.
   PubMed Web of Science ®Google Scholar
• Carroll JE, Small BJ, Tometich DB, et al. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: interaction with genotype. Cancer-Am Cancer Soc. 2019;125(24):4516–4524. doi: 10.1002/cncr.32489.
   Web of Science ®Google Scholar
• Sienski G, Narayan P, Bonner JM, et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med. 2021;13(583):eaaz4564. doi: 10.1126/scitranslmed.aaz4564.
   PubMed Web of Science ®Google Scholar
• Kemp SB, Carpenter ES, Steele NG, et al. Apolipoprotein e promotes immune suppression in pancreatic cancer through NF-kappa B-Mediated production of CXCL1. Cancer Res. 2021;81(16):4305–4318. doi: 10.1158/0008-5472.CAN-20-3929.
   PubMed Web of Science ®Google Scholar
• Zheng P, Luo Q, Wang W, et al. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional apolipoprotein E. Cell Death Dis. 2018;9(4):434. doi: 10.1038/s41419-018-0465-5.
   PubMed Web of Science ®Google Scholar
• Tavazoie MF, Pollack I, Tanqueco R, et al. LXR/ApoE activation restricts innate immune suppression in cancer. Cell. 2018;172(4):825–840.e18. doi: 10.1016/j.cell.2017.12.026.
   PubMed Web of Science ®Google Scholar
• Miao YR, Zhang Q, Lei Q, et al. ImmuCellAI: a unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci. 2020;7(7):1902880. doi: 10.1002/advs.201902880.
   Web of Science ®Google Scholar
• Xu L, Deng C, Pang B, et al. TIP: a web server for resolving tumor immunophenotype profiling. Cancer Res. 2018;78(23):6575–6580. doi: 10.1158/0008-5472.CAN-18-0689.
   PubMed Web of Science ®Google Scholar
• Tian S, Peng P, Li J, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/beta-catenin signaling pathway. Aging. 2020;12(4):3574–3593. doi: 10.18632/aging.102831.
   PubMedGoogle Scholar
• Zhao Y, Kong LX, Feng FS, et al. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study. BMC Cancer. 2022;22(1):311. doi: 10.1186/s12885-022-09433-3.
   PubMed Web of Science ®Google Scholar
• Zhao M, Bu Y, Feng J, et al. SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer. Cancer Lett. 2020;470:54–63. doi: 10.1016/j.canlet.2019.11.032.
   PubMed Web of Science ®Google Scholar
• Li XJ, Li QL, Ju LG, et al. Deficiency of histone methyltransferase SET domain-containing 2 in liver leads to abnormal lipid metabolism and HCC. Hepatology. 2021;73(5):1797–1815. doi: 10.1002/hep.31594.
   PubMed Web of Science ®Google Scholar
• Seo J, Jeong DW, Park JW, et al. Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells. Commun Biol. 2020;3(1):638. doi: 10.1038/s42003-020-01367-5.
   PubMed Web of Science ®Google Scholar
• Gu L, Zhu Y, Lin X, et al. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 2020;39(11):2437–2449. doi: 10.1038/s41388-020-1156-0.
   PubMed Web of Science ®Google Scholar
• Jiang X, Qian H, Ding WX. New glance at the role of TM6SF2 in lipid metabolism and liver cancer. Hepatology. 2021;74(3):1141–1144. doi: 10.1002/hep.31851.
   PubMed Web of Science ®Google Scholar
• Guo Y, Huang B, Li R, et al. Low APOA-1 expression in hepatocellular carcinoma patients is associated with DNA methylation and poor overall survival. Front Genet. 2021;12:760744. doi: 10.3389/fgene.2021.760744.
   PubMed Web of Science ®Google Scholar
• Ho DW, Lo RC, Chan LK, et al. Molecular pathogenesis of hepatocellular carcinoma. Liver Cancer. 2016;5(4):290–302. doi: 10.1159/000449340.
   PubMed Web of Science ®Google Scholar
• De Zhu J. The altered DNA methylation pattern and its implications in liver cancer. Cell Res. 2005;15(4):272–280. doi: 10.1038/sj.cr.7290296.
   PubMed Web of Science ®Google Scholar
• Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18(12):759–772. doi: 10.1038/s41577-018-0051-1.
   PubMed Web of Science ®Google Scholar
• Wolters FJ, Yang Q, Biggs ML, et al. The impact of APOE genotype on survival: results of 38,537 participants from six population-based cohorts (E2-CHARGE). PLoS One. 2019;14(7):e0219668. doi: 10.1371/journal.pone.0219668.
   PubMed Web of Science ®Google Scholar
• Ostendorf BN, Bilanovic J, Adaku N, et al. Common germline variants of the human APOE gene modulate melanoma progression and survival. Nat Med. 2020;26(7):1048–1053. doi: 10.1038/s41591-020-0879-3.
   PubMed Web of Science ®Google Scholar
• Chen YC, Pohl G, Wang TL, et al. Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res. 2005;65(1):331–337. doi: 10.1158/0008-5472.331.65.1.
   PubMed Web of Science ®Google Scholar
• Su WP, Chen YT, Lai WW, et al. Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer. Lung Cancer. 2011;71(1):28–33. doi: 10.1016/j.lungcan.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Dai Y, Qiang W, Lin K, et al. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Cancer Immunol Immunother. 2021;70(4):967–979. doi: 10.1007/s00262-020-02743-0.
   PubMed Web of Science ®Google Scholar
• Xue R, Zhang Q, Cao Q, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612(7938):141–147. doi: 10.1038/s41586-022-05400-x.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu LM, Wu J. Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm. 2011;2011:949072. doi: 10.1155/2011/949072.
   PubMed Web of Science ®Google Scholar